Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ratzinger

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Lupus|June 28, 2014
Cerebral large vessel vasculitis in systemic lupus erythematosusB C Böckle, D Jara, K Aichhorn, et al.
The Journal of Investigative Dermatology|May 12, 2001
Interleukin-16 supports the migration of Langerhans cells, partly in a CD4-independent wayP Stoitzner, G Ratzinger, F Koch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2000
Production of IL-12 by human monocyte-derived dendritic cells is optimal when the stimulus is given at the onset of maturation, and is further enhanced by IL-4S Ebner, G Ratzinger, B Krösbacher, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 27, 2024
Characteristics and management of generalized pustular psoriasis (GPP): Experience from the Central and Eastern Europe (CEE) GPP Expert NetworkP Wolf, R Ceovic, C Conrad, et al.
Scientific Reports|September 5, 2022
Real-world effectiveness of anti-interleukin-23 antibodies in chronic plaque-type psoriasis of patients from the Austrian Psoriasis Registry (PsoRA)T Graier, W Weger, C Jonak, et al.
Scientific Reports|March 27, 2024
Author Correction: Real-world effectiveness of anti-interleukin-23 antibodies in chronic plaque-type psoriasis of patients from the Austrian Psoriasis Registry (PsoRA)T Graier, W Weger, C Jonak, et al.
The British Journal of Dermatology|July 24, 2004
Temozolomide and interferon alpha 2b in metastatic melanoma stage IVE Richtig, R Hofmann-Wellenhof, H Pehamberger, et al.
The British Journal of Dermatology|December 8, 2020
Biologic drug survival rates in the era of anti-interleukin-17 antibodies: a time-period-adjusted registry analysisT Graier, W Salmhofer, C Jonak, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Lupus|June 28, 2014
Cerebral large vessel vasculitis in systemic lupus erythematosusB C Böckle, D Jara, K Aichhorn, et al.
The Journal of Investigative Dermatology|May 12, 2001
Interleukin-16 supports the migration of Langerhans cells, partly in a CD4-independent wayP Stoitzner, G Ratzinger, F Koch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2000
Production of IL-12 by human monocyte-derived dendritic cells is optimal when the stimulus is given at the onset of maturation, and is further enhanced by IL-4S Ebner, G Ratzinger, B Krösbacher, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 27, 2024
Characteristics and management of generalized pustular psoriasis (GPP): Experience from the Central and Eastern Europe (CEE) GPP Expert NetworkP Wolf, R Ceovic, C Conrad, et al.
Scientific Reports|September 5, 2022
Real-world effectiveness of anti-interleukin-23 antibodies in chronic plaque-type psoriasis of patients from the Austrian Psoriasis Registry (PsoRA)T Graier, W Weger, C Jonak, et al.
Scientific Reports|March 27, 2024
Author Correction: Real-world effectiveness of anti-interleukin-23 antibodies in chronic plaque-type psoriasis of patients from the Austrian Psoriasis Registry (PsoRA)T Graier, W Weger, C Jonak, et al.
The British Journal of Dermatology|July 24, 2004
Temozolomide and interferon alpha 2b in metastatic melanoma stage IVE Richtig, R Hofmann-Wellenhof, H Pehamberger, et al.
The British Journal of Dermatology|December 8, 2020
Biologic drug survival rates in the era of anti-interleukin-17 antibodies: a time-period-adjusted registry analysisT Graier, W Salmhofer, C Jonak, et al.
Pageof 2